COVID-19 Impact on Global High Potency API, Market Insights and Forecast to 2026
High Potency API market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global High Potency API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the High Potency API market is segmented into
The High Potency API market is analysed and market size information is provided by regions (countries).
The key regions covered in the High Potency API market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and High Potency API Market Share Analysis
High Potency API market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in High Potency API business, the date to enter into the High Potency API market, High Potency API product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the High Potency API market is segmented into
- Synthetic HPAPIs
- Biotech HPAPIs
- Oncology
- Hormonal Disorders
- Glaucoma
- Other
The High Potency API market is analysed and market size information is provided by regions (countries).
The key regions covered in the High Potency API market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and High Potency API Market Share Analysis
High Potency API market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in High Potency API business, the date to enter into the High Potency API market, High Potency API product introduction, recent developments, etc.
The major vendors covered:
- Pfizer
- Novartis International
- Sanofi
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Teva Pharmaceutical
- Eli Lilly and Company
- GlaxoSmithKline
- Merck & Co
- AbbVie
- Johnson & Johnson
- Bayer
- Mylan
1 STUDY COVERAGE
1.1 High Potency API Product Introduction
1.2 Market Segments
1.3 Key High Potency API Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global High Potency API Market Size Growth Rate by Type
1.4.2 Synthetic HPAPIs
1.4.3 Biotech HPAPIs
1.5 Market by Application
1.5.1 Global High Potency API Market Size Growth Rate by Application
1.5.2 Oncology
1.5.3 Hormonal Disorders
1.5.4 Glaucoma
1.5.5 Other
1.6 Coronavirus Disease 2019 (Covid-19): High Potency API Industry Impact
1.6.1 How the Covid-19 is Affecting the High Potency API Industry
1.6.1.1 High Potency API Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and High Potency API Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for High Potency API Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global High Potency API Market Size Estimates and Forecasts
2.1.1 Global High Potency API Revenue 2015-2026
2.1.2 Global High Potency API Sales 2015-2026
2.2 High Potency API Market Size by Region: 2020 Versus 2026
2.2.1 Global High Potency API Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global High Potency API Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL HIGH POTENCY API COMPETITOR LANDSCAPE BY PLAYERS
3.1 High Potency API Sales by Manufacturers
3.1.1 High Potency API Sales by Manufacturers (2015-2020)
3.1.2 High Potency API Sales Market Share by Manufacturers (2015-2020)
3.2 High Potency API Revenue by Manufacturers
3.2.1 High Potency API Revenue by Manufacturers (2015-2020)
3.2.2 High Potency API Revenue Share by Manufacturers (2015-2020)
3.2.3 Global High Potency API Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by High Potency API Revenue in 2019
3.2.5 Global High Potency API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 High Potency API Price by Manufacturers
3.4 High Potency API Manufacturing Base Distribution, Product Types
3.4.1 High Potency API Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers High Potency API Product Type
3.4.3 Date of International Manufacturers Enter into High Potency API Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global High Potency API Market Size by Type (2015-2020)
4.1.1 Global High Potency API Sales by Type (2015-2020)
4.1.2 Global High Potency API Revenue by Type (2015-2020)
4.1.3 High Potency API Average Selling Price (ASP) by Type (2015-2026)
4.2 Global High Potency API Market Size Forecast by Type (2021-2026)
4.2.1 Global High Potency API Sales Forecast by Type (2021-2026)
4.2.2 Global High Potency API Revenue Forecast by Type (2021-2026)
4.2.3 High Potency API Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global High Potency API Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global High Potency API Market Size by Application (2015-2020)
5.1.1 Global High Potency API Sales by Application (2015-2020)
5.1.2 Global High Potency API Revenue by Application (2015-2020)
5.1.3 High Potency API Price by Application (2015-2020)
5.2 High Potency API Market Size Forecast by Application (2021-2026)
5.2.1 Global High Potency API Sales Forecast by Application (2021-2026)
5.2.2 Global High Potency API Revenue Forecast by Application (2021-2026)
5.2.3 Global High Potency API Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America High Potency API by Country
6.1.1 North America High Potency API Sales by Country
6.1.2 North America High Potency API Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America High Potency API Market Facts & Figures by Type
6.3 North America High Potency API Market Facts & Figures by Application
7 EUROPE
7.1 Europe High Potency API by Country
7.1.1 Europe High Potency API Sales by Country
7.1.2 Europe High Potency API Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe High Potency API Market Facts & Figures by Type
7.3 Europe High Potency API Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific High Potency API by Region
8.1.1 Asia Pacific High Potency API Sales by Region
8.1.2 Asia Pacific High Potency API Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific High Potency API Market Facts & Figures by Type
8.3 Asia Pacific High Potency API Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America High Potency API by Country
9.1.1 Latin America High Potency API Sales by Country
9.1.2 Latin America High Potency API Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America High Potency API Market Facts & Figures by Type
9.3 Central & South America High Potency API Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa High Potency API by Country
10.1.1 Middle East and Africa High Potency API Sales by Country
10.1.2 Middle East and Africa High Potency API Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa High Potency API Market Facts & Figures by Type
10.3 Middle East and Africa High Potency API Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description, Business Overview and Total Revenue
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer High Potency API Products Offered
11.1.5 Pfizer Recent Development
11.2 Novartis International
11.2.1 Novartis International Corporation Information
11.2.2 Novartis International Description, Business Overview and Total Revenue
11.2.3 Novartis International Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novartis International High Potency API Products Offered
11.2.5 Novartis International Recent Development
11.3 Sanofi
11.3.1 Sanofi Corporation Information
11.3.2 Sanofi Description, Business Overview and Total Revenue
11.3.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Sanofi High Potency API Products Offered
11.3.5 Sanofi Recent Development
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Corporation Information
11.4.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
11.4.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Boehringer Ingelheim High Potency API Products Offered
11.4.5 Boehringer Ingelheim Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Corporation Information
11.5.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue
11.5.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Bristol-Myers Squibb High Potency API Products Offered
11.5.5 Bristol-Myers Squibb Recent Development
11.6 Teva Pharmaceutical
11.6.1 Teva Pharmaceutical Corporation Information
11.6.2 Teva Pharmaceutical Description, Business Overview and Total Revenue
11.6.3 Teva Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Teva Pharmaceutical High Potency API Products Offered
11.6.5 Teva Pharmaceutical Recent Development
11.7 Eli Lilly and Company
11.7.1 Eli Lilly and Company Corporation Information
11.7.2 Eli Lilly and Company Description, Business Overview and Total Revenue
11.7.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Eli Lilly and Company High Potency API Products Offered
11.7.5 Eli Lilly and Company Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Corporation Information
11.8.2 GlaxoSmithKline Description, Business Overview and Total Revenue
11.8.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.8.4 GlaxoSmithKline High Potency API Products Offered
11.8.5 GlaxoSmithKline Recent Development
11.9 Merck & Co
11.9.1 Merck & Co Corporation Information
11.9.2 Merck & Co Description, Business Overview and Total Revenue
11.9.3 Merck & Co Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Merck & Co High Potency API Products Offered
11.9.5 Merck & Co Recent Development
11.10 AbbVie
11.10.1 AbbVie Corporation Information
11.10.2 AbbVie Description, Business Overview and Total Revenue
11.10.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.10.4 AbbVie High Potency API Products Offered
11.10.5 AbbVie Recent Development
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description, Business Overview and Total Revenue
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer High Potency API Products Offered
11.1.5 Pfizer Recent Development
11.12 Bayer
11.12.1 Bayer Corporation Information
11.12.2 Bayer Description, Business Overview and Total Revenue
11.12.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Bayer Products Offered
11.12.5 Bayer Recent Development
11.13 Mylan
11.13.1 Mylan Corporation Information
11.13.2 Mylan Description, Business Overview and Total Revenue
11.13.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Mylan Products Offered
11.13.5 Mylan Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 High Potency API Market Estimates and Projections by Region
12.1.1 Global High Potency API Sales Forecast by Regions 2021-2026
12.1.2 Global High Potency API Revenue Forecast by Regions 2021-2026
12.2 North America High Potency API Market Size Forecast (2021-2026)
12.2.1 North America: High Potency API Sales Forecast (2021-2026)
12.2.2 North America: High Potency API Revenue Forecast (2021-2026)
12.2.3 North America: High Potency API Market Size Forecast by Country (2021-2026)
12.3 Europe High Potency API Market Size Forecast (2021-2026)
12.3.1 Europe: High Potency API Sales Forecast (2021-2026)
12.3.2 Europe: High Potency API Revenue Forecast (2021-2026)
12.3.3 Europe: High Potency API Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific High Potency API Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: High Potency API Sales Forecast (2021-2026)
12.4.2 Asia Pacific: High Potency API Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: High Potency API Market Size Forecast by Region (2021-2026)
12.5 Latin America High Potency API Market Size Forecast (2021-2026)
12.5.1 Latin America: High Potency API Sales Forecast (2021-2026)
12.5.2 Latin America: High Potency API Revenue Forecast (2021-2026)
12.5.3 Latin America: High Potency API Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa High Potency API Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: High Potency API Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: High Potency API Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: High Potency API Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key High Potency API Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 High Potency API Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 High Potency API Product Introduction
1.2 Market Segments
1.3 Key High Potency API Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global High Potency API Market Size Growth Rate by Type
1.4.2 Synthetic HPAPIs
1.4.3 Biotech HPAPIs
1.5 Market by Application
1.5.1 Global High Potency API Market Size Growth Rate by Application
1.5.2 Oncology
1.5.3 Hormonal Disorders
1.5.4 Glaucoma
1.5.5 Other
1.6 Coronavirus Disease 2019 (Covid-19): High Potency API Industry Impact
1.6.1 How the Covid-19 is Affecting the High Potency API Industry
1.6.1.1 High Potency API Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and High Potency API Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for High Potency API Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global High Potency API Market Size Estimates and Forecasts
2.1.1 Global High Potency API Revenue 2015-2026
2.1.2 Global High Potency API Sales 2015-2026
2.2 High Potency API Market Size by Region: 2020 Versus 2026
2.2.1 Global High Potency API Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global High Potency API Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL HIGH POTENCY API COMPETITOR LANDSCAPE BY PLAYERS
3.1 High Potency API Sales by Manufacturers
3.1.1 High Potency API Sales by Manufacturers (2015-2020)
3.1.2 High Potency API Sales Market Share by Manufacturers (2015-2020)
3.2 High Potency API Revenue by Manufacturers
3.2.1 High Potency API Revenue by Manufacturers (2015-2020)
3.2.2 High Potency API Revenue Share by Manufacturers (2015-2020)
3.2.3 Global High Potency API Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by High Potency API Revenue in 2019
3.2.5 Global High Potency API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 High Potency API Price by Manufacturers
3.4 High Potency API Manufacturing Base Distribution, Product Types
3.4.1 High Potency API Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers High Potency API Product Type
3.4.3 Date of International Manufacturers Enter into High Potency API Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global High Potency API Market Size by Type (2015-2020)
4.1.1 Global High Potency API Sales by Type (2015-2020)
4.1.2 Global High Potency API Revenue by Type (2015-2020)
4.1.3 High Potency API Average Selling Price (ASP) by Type (2015-2026)
4.2 Global High Potency API Market Size Forecast by Type (2021-2026)
4.2.1 Global High Potency API Sales Forecast by Type (2021-2026)
4.2.2 Global High Potency API Revenue Forecast by Type (2021-2026)
4.2.3 High Potency API Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global High Potency API Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global High Potency API Market Size by Application (2015-2020)
5.1.1 Global High Potency API Sales by Application (2015-2020)
5.1.2 Global High Potency API Revenue by Application (2015-2020)
5.1.3 High Potency API Price by Application (2015-2020)
5.2 High Potency API Market Size Forecast by Application (2021-2026)
5.2.1 Global High Potency API Sales Forecast by Application (2021-2026)
5.2.2 Global High Potency API Revenue Forecast by Application (2021-2026)
5.2.3 Global High Potency API Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America High Potency API by Country
6.1.1 North America High Potency API Sales by Country
6.1.2 North America High Potency API Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America High Potency API Market Facts & Figures by Type
6.3 North America High Potency API Market Facts & Figures by Application
7 EUROPE
7.1 Europe High Potency API by Country
7.1.1 Europe High Potency API Sales by Country
7.1.2 Europe High Potency API Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe High Potency API Market Facts & Figures by Type
7.3 Europe High Potency API Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific High Potency API by Region
8.1.1 Asia Pacific High Potency API Sales by Region
8.1.2 Asia Pacific High Potency API Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific High Potency API Market Facts & Figures by Type
8.3 Asia Pacific High Potency API Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America High Potency API by Country
9.1.1 Latin America High Potency API Sales by Country
9.1.2 Latin America High Potency API Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America High Potency API Market Facts & Figures by Type
9.3 Central & South America High Potency API Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa High Potency API by Country
10.1.1 Middle East and Africa High Potency API Sales by Country
10.1.2 Middle East and Africa High Potency API Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa High Potency API Market Facts & Figures by Type
10.3 Middle East and Africa High Potency API Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description, Business Overview and Total Revenue
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer High Potency API Products Offered
11.1.5 Pfizer Recent Development
11.2 Novartis International
11.2.1 Novartis International Corporation Information
11.2.2 Novartis International Description, Business Overview and Total Revenue
11.2.3 Novartis International Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novartis International High Potency API Products Offered
11.2.5 Novartis International Recent Development
11.3 Sanofi
11.3.1 Sanofi Corporation Information
11.3.2 Sanofi Description, Business Overview and Total Revenue
11.3.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Sanofi High Potency API Products Offered
11.3.5 Sanofi Recent Development
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Corporation Information
11.4.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
11.4.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Boehringer Ingelheim High Potency API Products Offered
11.4.5 Boehringer Ingelheim Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Corporation Information
11.5.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue
11.5.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Bristol-Myers Squibb High Potency API Products Offered
11.5.5 Bristol-Myers Squibb Recent Development
11.6 Teva Pharmaceutical
11.6.1 Teva Pharmaceutical Corporation Information
11.6.2 Teva Pharmaceutical Description, Business Overview and Total Revenue
11.6.3 Teva Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Teva Pharmaceutical High Potency API Products Offered
11.6.5 Teva Pharmaceutical Recent Development
11.7 Eli Lilly and Company
11.7.1 Eli Lilly and Company Corporation Information
11.7.2 Eli Lilly and Company Description, Business Overview and Total Revenue
11.7.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Eli Lilly and Company High Potency API Products Offered
11.7.5 Eli Lilly and Company Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Corporation Information
11.8.2 GlaxoSmithKline Description, Business Overview and Total Revenue
11.8.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.8.4 GlaxoSmithKline High Potency API Products Offered
11.8.5 GlaxoSmithKline Recent Development
11.9 Merck & Co
11.9.1 Merck & Co Corporation Information
11.9.2 Merck & Co Description, Business Overview and Total Revenue
11.9.3 Merck & Co Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Merck & Co High Potency API Products Offered
11.9.5 Merck & Co Recent Development
11.10 AbbVie
11.10.1 AbbVie Corporation Information
11.10.2 AbbVie Description, Business Overview and Total Revenue
11.10.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.10.4 AbbVie High Potency API Products Offered
11.10.5 AbbVie Recent Development
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description, Business Overview and Total Revenue
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer High Potency API Products Offered
11.1.5 Pfizer Recent Development
11.12 Bayer
11.12.1 Bayer Corporation Information
11.12.2 Bayer Description, Business Overview and Total Revenue
11.12.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Bayer Products Offered
11.12.5 Bayer Recent Development
11.13 Mylan
11.13.1 Mylan Corporation Information
11.13.2 Mylan Description, Business Overview and Total Revenue
11.13.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Mylan Products Offered
11.13.5 Mylan Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 High Potency API Market Estimates and Projections by Region
12.1.1 Global High Potency API Sales Forecast by Regions 2021-2026
12.1.2 Global High Potency API Revenue Forecast by Regions 2021-2026
12.2 North America High Potency API Market Size Forecast (2021-2026)
12.2.1 North America: High Potency API Sales Forecast (2021-2026)
12.2.2 North America: High Potency API Revenue Forecast (2021-2026)
12.2.3 North America: High Potency API Market Size Forecast by Country (2021-2026)
12.3 Europe High Potency API Market Size Forecast (2021-2026)
12.3.1 Europe: High Potency API Sales Forecast (2021-2026)
12.3.2 Europe: High Potency API Revenue Forecast (2021-2026)
12.3.3 Europe: High Potency API Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific High Potency API Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: High Potency API Sales Forecast (2021-2026)
12.4.2 Asia Pacific: High Potency API Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: High Potency API Market Size Forecast by Region (2021-2026)
12.5 Latin America High Potency API Market Size Forecast (2021-2026)
12.5.1 Latin America: High Potency API Sales Forecast (2021-2026)
12.5.2 Latin America: High Potency API Revenue Forecast (2021-2026)
12.5.3 Latin America: High Potency API Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa High Potency API Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: High Potency API Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: High Potency API Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: High Potency API Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key High Potency API Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 High Potency API Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. High Potency API Market Segments
Table 2. Ranking of Global Top High Potency API Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global High Potency API Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Synthetic HPAPIs
Table 5. Major Manufacturers of Biotech HPAPIs
Table 6. COVID-19 Impact Global Market: (Four High Potency API Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for High Potency API Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for High Potency API Players to Combat Covid-19 Impact
Table 11. Global High Potency API Market Size Growth Rate by Application 2020-2026 (K MT)
Table 12. Global High Potency API Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 13. Global High Potency API Sales by Regions 2015-2020 (K MT)
Table 14. Global High Potency API Sales Market Share by Regions (2015-2020)
Table 15. Global High Potency API Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global High Potency API Sales by Manufacturers (2015-2020) (K MT)
Table 17. Global High Potency API Sales Share by Manufacturers (2015-2020)
Table 18. Global High Potency API Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global High Potency API by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in High Potency API as of 2019)
Table 20. High Potency API Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. High Potency API Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers High Potency API Price (2015-2020) (USD/MT)
Table 23. High Potency API Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers High Potency API Product Type
Table 25. Date of International Manufacturers Enter into High Potency API Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global High Potency API Sales by Type (2015-2020) (K MT)
Table 28. Global High Potency API Sales Share by Type (2015-2020)
Table 29. Global High Potency API Revenue by Type (2015-2020) (US$ Million)
Table 30. Global High Potency API Revenue Share by Type (2015-2020)
Table 31. High Potency API Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 32. Global High Potency API Sales by Application (2015-2020) (K MT)
Table 33. Global High Potency API Sales Share by Application (2015-2020)
Table 34. North America High Potency API Sales by Country (2015-2020) (K MT)
Table 35. North America High Potency API Sales Market Share by Country (2015-2020)
Table 36. North America High Potency API Revenue by Country (2015-2020) (US$ Million)
Table 37. North America High Potency API Revenue Market Share by Country (2015-2020)
Table 38. North America High Potency API Sales by Type (2015-2020) (K MT)
Table 39. North America High Potency API Sales Market Share by Type (2015-2020)
Table 40. North America High Potency API Sales by Application (2015-2020) (K MT)
Table 41. North America High Potency API Sales Market Share by Application (2015-2020)
Table 42. Europe High Potency API Sales by Country (2015-2020) (K MT)
Table 43. Europe High Potency API Sales Market Share by Country (2015-2020)
Table 44. Europe High Potency API Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe High Potency API Revenue Market Share by Country (2015-2020)
Table 46. Europe High Potency API Sales by Type (2015-2020) (K MT)
Table 47. Europe High Potency API Sales Market Share by Type (2015-2020)
Table 48. Europe High Potency API Sales by Application (2015-2020) (K MT)
Table 49. Europe High Potency API Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific High Potency API Sales by Region (2015-2020) (K MT)
Table 51. Asia Pacific High Potency API Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific High Potency API Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific High Potency API Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific High Potency API Sales by Type (2015-2020) (K MT)
Table 55. Asia Pacific High Potency API Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific High Potency API Sales by Application (2015-2020) (K MT)
Table 57. Asia Pacific High Potency API Sales Market Share by Application (2015-2020)
Table 58. Latin America High Potency API Sales by Country (2015-2020) (K MT)
Table 59. Latin America High Potency API Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa High Potency API Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America High Potency API Revenue Market Share by Country (2015-2020)
Table 62. Latin America High Potency API Sales by Type (2015-2020) (K MT)
Table 63. Latin America High Potency API Sales Market Share by Type (2015-2020)
Table 64. Latin America High Potency API Sales by Application (2015-2020) (K MT)
Table 65. Latin America High Potency API Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa High Potency API Sales by Country (2015-2020) (K MT)
Table 67. Middle East and Africa High Potency API Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa High Potency API Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa High Potency API Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa High Potency API Sales by Type (2015-2020) (K MT)
Table 71. Middle East and Africa High Potency API Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa High Potency API Sales by Application (2015-2020) (K MT)
Table 73. Middle East and Africa High Potency API Sales Market Share by Application (2015-2020)
Table 74. Pfizer Corporation Information
Table 75. Pfizer Description and Major Businesses
Table 76. Pfizer High Potency API Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Pfizer Product
Table 78. Pfizer Recent Development
Table 79. Novartis International Corporation Information
Table 80. Novartis International Description and Major Businesses
Table 81. Novartis International High Potency API Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Novartis International Product
Table 83. Novartis International Recent Development
Table 84. Sanofi Corporation Information
Table 85. Sanofi Description and Major Businesses
Table 86. Sanofi High Potency API Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Sanofi Product
Table 88. Sanofi Recent Development
Table 89. Boehringer Ingelheim Corporation Information
Table 90. Boehringer Ingelheim Description and Major Businesses
Table 91. Boehringer Ingelheim High Potency API Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Boehringer Ingelheim Product
Table 93. Boehringer Ingelheim Recent Development
Table 94. Bristol-Myers Squibb Corporation Information
Table 95. Bristol-Myers Squibb Description and Major Businesses
Table 96. Bristol-Myers Squibb High Potency API Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Bristol-Myers Squibb Product
Table 98. Bristol-Myers Squibb Recent Development
Table 99. Teva Pharmaceutical Corporation Information
Table 100. Teva Pharmaceutical Description and Major Businesses
Table 101. Teva Pharmaceutical High Potency API Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Teva Pharmaceutical Product
Table 103. Teva Pharmaceutical Recent Development
Table 104. Eli Lilly and Company Corporation Information
Table 105. Eli Lilly and Company Description and Major Businesses
Table 106. Eli Lilly and Company High Potency API Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Eli Lilly and Company Product
Table 108. Eli Lilly and Company Recent Development
Table 109. GlaxoSmithKline Corporation Information
Table 110. GlaxoSmithKline Description and Major Businesses
Table 111. GlaxoSmithKline High Potency API Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. GlaxoSmithKline Product
Table 113. GlaxoSmithKline Recent Development
Table 114. Merck & Co Corporation Information
Table 115. Merck & Co Description and Major Businesses
Table 116. Merck & Co High Potency API Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Merck & Co Product
Table 118. Merck & Co Recent Development
Table 119. AbbVie Corporation Information
Table 120. AbbVie Description and Major Businesses
Table 121. AbbVie High Potency API Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. AbbVie Product
Table 123. AbbVie Recent Development
Table 124. Johnson & Johnson Corporation Information
Table 125. Johnson & Johnson Description and Major Businesses
Table 126. Johnson & Johnson High Potency API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 127. Johnson & Johnson Product
Table 128. Johnson & Johnson Recent Development
Table 129. Bayer Corporation Information
Table 130. Bayer Description and Major Businesses
Table 131. Bayer High Potency API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 132. Bayer Product
Table 133. Bayer Recent Development
Table 134. Mylan Corporation Information
Table 135. Mylan Description and Major Businesses
Table 136. Mylan High Potency API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 137. Mylan Product
Table 138. Mylan Recent Development
Table 139. Global High Potency API Sales Forecast by Regions (2021-2026) (K MT)
Table 140. Global High Potency API Sales Market Share Forecast by Regions (2021-2026)
Table 141. Global High Potency API Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 142. Global High Potency API Revenue Market Share Forecast by Regions (2021-2026)
Table 143. North America: High Potency API Sales Forecast by Country (2021-2026) (K MT)
Table 144. North America: High Potency API Revenue Forecast by Country (2021-2026) (US$ Million)
Table 145. Europe: High Potency API Sales Forecast by Country (2021-2026) (K MT)
Table 146. Europe: High Potency API Revenue Forecast by Country (2021-2026) (US$ Million)
Table 147. Asia Pacific: High Potency API Sales Forecast by Region (2021-2026) (K MT)
Table 148. Asia Pacific: High Potency API Revenue Forecast by Region (2021-2026) (US$ Million)
Table 149. Latin America: High Potency API Sales Forecast by Country (2021-2026) (K MT)
Table 150. Latin America: High Potency API Revenue Forecast by Country (2021-2026) (US$ Million)
Table 151. Middle East and Africa: High Potency API Sales Forecast by Country (2021-2026) (K MT)
Table 152. Middle East and Africa: High Potency API Revenue Forecast by Country (2021-2026) (US$ Million)
Table 153. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 154. Key Challenges
Table 155. Market Risks
Table 156. Main Points Interviewed from Key High Potency API Players
Table 157. High Potency API Customers List
Table 158. High Potency API Distributors List
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
Table 1. High Potency API Market Segments
Table 2. Ranking of Global Top High Potency API Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global High Potency API Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Synthetic HPAPIs
Table 5. Major Manufacturers of Biotech HPAPIs
Table 6. COVID-19 Impact Global Market: (Four High Potency API Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for High Potency API Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for High Potency API Players to Combat Covid-19 Impact
Table 11. Global High Potency API Market Size Growth Rate by Application 2020-2026 (K MT)
Table 12. Global High Potency API Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 13. Global High Potency API Sales by Regions 2015-2020 (K MT)
Table 14. Global High Potency API Sales Market Share by Regions (2015-2020)
Table 15. Global High Potency API Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global High Potency API Sales by Manufacturers (2015-2020) (K MT)
Table 17. Global High Potency API Sales Share by Manufacturers (2015-2020)
Table 18. Global High Potency API Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global High Potency API by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in High Potency API as of 2019)
Table 20. High Potency API Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. High Potency API Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers High Potency API Price (2015-2020) (USD/MT)
Table 23. High Potency API Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers High Potency API Product Type
Table 25. Date of International Manufacturers Enter into High Potency API Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global High Potency API Sales by Type (2015-2020) (K MT)
Table 28. Global High Potency API Sales Share by Type (2015-2020)
Table 29. Global High Potency API Revenue by Type (2015-2020) (US$ Million)
Table 30. Global High Potency API Revenue Share by Type (2015-2020)
Table 31. High Potency API Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 32. Global High Potency API Sales by Application (2015-2020) (K MT)
Table 33. Global High Potency API Sales Share by Application (2015-2020)
Table 34. North America High Potency API Sales by Country (2015-2020) (K MT)
Table 35. North America High Potency API Sales Market Share by Country (2015-2020)
Table 36. North America High Potency API Revenue by Country (2015-2020) (US$ Million)
Table 37. North America High Potency API Revenue Market Share by Country (2015-2020)
Table 38. North America High Potency API Sales by Type (2015-2020) (K MT)
Table 39. North America High Potency API Sales Market Share by Type (2015-2020)
Table 40. North America High Potency API Sales by Application (2015-2020) (K MT)
Table 41. North America High Potency API Sales Market Share by Application (2015-2020)
Table 42. Europe High Potency API Sales by Country (2015-2020) (K MT)
Table 43. Europe High Potency API Sales Market Share by Country (2015-2020)
Table 44. Europe High Potency API Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe High Potency API Revenue Market Share by Country (2015-2020)
Table 46. Europe High Potency API Sales by Type (2015-2020) (K MT)
Table 47. Europe High Potency API Sales Market Share by Type (2015-2020)
Table 48. Europe High Potency API Sales by Application (2015-2020) (K MT)
Table 49. Europe High Potency API Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific High Potency API Sales by Region (2015-2020) (K MT)
Table 51. Asia Pacific High Potency API Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific High Potency API Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific High Potency API Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific High Potency API Sales by Type (2015-2020) (K MT)
Table 55. Asia Pacific High Potency API Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific High Potency API Sales by Application (2015-2020) (K MT)
Table 57. Asia Pacific High Potency API Sales Market Share by Application (2015-2020)
Table 58. Latin America High Potency API Sales by Country (2015-2020) (K MT)
Table 59. Latin America High Potency API Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa High Potency API Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America High Potency API Revenue Market Share by Country (2015-2020)
Table 62. Latin America High Potency API Sales by Type (2015-2020) (K MT)
Table 63. Latin America High Potency API Sales Market Share by Type (2015-2020)
Table 64. Latin America High Potency API Sales by Application (2015-2020) (K MT)
Table 65. Latin America High Potency API Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa High Potency API Sales by Country (2015-2020) (K MT)
Table 67. Middle East and Africa High Potency API Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa High Potency API Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa High Potency API Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa High Potency API Sales by Type (2015-2020) (K MT)
Table 71. Middle East and Africa High Potency API Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa High Potency API Sales by Application (2015-2020) (K MT)
Table 73. Middle East and Africa High Potency API Sales Market Share by Application (2015-2020)
Table 74. Pfizer Corporation Information
Table 75. Pfizer Description and Major Businesses
Table 76. Pfizer High Potency API Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Pfizer Product
Table 78. Pfizer Recent Development
Table 79. Novartis International Corporation Information
Table 80. Novartis International Description and Major Businesses
Table 81. Novartis International High Potency API Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Novartis International Product
Table 83. Novartis International Recent Development
Table 84. Sanofi Corporation Information
Table 85. Sanofi Description and Major Businesses
Table 86. Sanofi High Potency API Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Sanofi Product
Table 88. Sanofi Recent Development
Table 89. Boehringer Ingelheim Corporation Information
Table 90. Boehringer Ingelheim Description and Major Businesses
Table 91. Boehringer Ingelheim High Potency API Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Boehringer Ingelheim Product
Table 93. Boehringer Ingelheim Recent Development
Table 94. Bristol-Myers Squibb Corporation Information
Table 95. Bristol-Myers Squibb Description and Major Businesses
Table 96. Bristol-Myers Squibb High Potency API Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Bristol-Myers Squibb Product
Table 98. Bristol-Myers Squibb Recent Development
Table 99. Teva Pharmaceutical Corporation Information
Table 100. Teva Pharmaceutical Description and Major Businesses
Table 101. Teva Pharmaceutical High Potency API Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Teva Pharmaceutical Product
Table 103. Teva Pharmaceutical Recent Development
Table 104. Eli Lilly and Company Corporation Information
Table 105. Eli Lilly and Company Description and Major Businesses
Table 106. Eli Lilly and Company High Potency API Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Eli Lilly and Company Product
Table 108. Eli Lilly and Company Recent Development
Table 109. GlaxoSmithKline Corporation Information
Table 110. GlaxoSmithKline Description and Major Businesses
Table 111. GlaxoSmithKline High Potency API Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. GlaxoSmithKline Product
Table 113. GlaxoSmithKline Recent Development
Table 114. Merck & Co Corporation Information
Table 115. Merck & Co Description and Major Businesses
Table 116. Merck & Co High Potency API Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Merck & Co Product
Table 118. Merck & Co Recent Development
Table 119. AbbVie Corporation Information
Table 120. AbbVie Description and Major Businesses
Table 121. AbbVie High Potency API Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. AbbVie Product
Table 123. AbbVie Recent Development
Table 124. Johnson & Johnson Corporation Information
Table 125. Johnson & Johnson Description and Major Businesses
Table 126. Johnson & Johnson High Potency API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 127. Johnson & Johnson Product
Table 128. Johnson & Johnson Recent Development
Table 129. Bayer Corporation Information
Table 130. Bayer Description and Major Businesses
Table 131. Bayer High Potency API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 132. Bayer Product
Table 133. Bayer Recent Development
Table 134. Mylan Corporation Information
Table 135. Mylan Description and Major Businesses
Table 136. Mylan High Potency API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 137. Mylan Product
Table 138. Mylan Recent Development
Table 139. Global High Potency API Sales Forecast by Regions (2021-2026) (K MT)
Table 140. Global High Potency API Sales Market Share Forecast by Regions (2021-2026)
Table 141. Global High Potency API Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 142. Global High Potency API Revenue Market Share Forecast by Regions (2021-2026)
Table 143. North America: High Potency API Sales Forecast by Country (2021-2026) (K MT)
Table 144. North America: High Potency API Revenue Forecast by Country (2021-2026) (US$ Million)
Table 145. Europe: High Potency API Sales Forecast by Country (2021-2026) (K MT)
Table 146. Europe: High Potency API Revenue Forecast by Country (2021-2026) (US$ Million)
Table 147. Asia Pacific: High Potency API Sales Forecast by Region (2021-2026) (K MT)
Table 148. Asia Pacific: High Potency API Revenue Forecast by Region (2021-2026) (US$ Million)
Table 149. Latin America: High Potency API Sales Forecast by Country (2021-2026) (K MT)
Table 150. Latin America: High Potency API Revenue Forecast by Country (2021-2026) (US$ Million)
Table 151. Middle East and Africa: High Potency API Sales Forecast by Country (2021-2026) (K MT)
Table 152. Middle East and Africa: High Potency API Revenue Forecast by Country (2021-2026) (US$ Million)
Table 153. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 154. Key Challenges
Table 155. Market Risks
Table 156. Main Points Interviewed from Key High Potency API Players
Table 157. High Potency API Customers List
Table 158. High Potency API Distributors List
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. High Potency API Product Picture
Figure 2. Global High Potency API Sales Market Share by Type in 2020 & 2026
Figure 3. Synthetic HPAPIs Product Picture
Figure 4. Biotech HPAPIs Product Picture
Figure 5. Global High Potency API Sales Market Share by Application in 2020 & 2026
Figure 6. Oncology
Figure 7. Hormonal Disorders
Figure 8. Glaucoma
Figure 9. Other
Figure 10. High Potency API Report Years Considered
Figure 11. Global High Potency API Market Size 2015-2026 (US$ Million)
Figure 12. Global High Potency API Sales 2015-2026 (K MT)
Figure 13. Global High Potency API Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global High Potency API Sales Market Share by Region (2015-2020)
Figure 15. Global High Potency API Sales Market Share by Region in 2019
Figure 16. Global High Potency API Revenue Market Share by Region (2015-2020)
Figure 17. Global High Potency API Revenue Market Share by Region in 2019
Figure 18. Global High Potency API Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by High Potency API Revenue in 2019
Figure 20. High Potency API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global High Potency API Sales Market Share by Type (2015-2020)
Figure 22. Global High Potency API Sales Market Share by Type in 2019
Figure 23. Global High Potency API Revenue Market Share by Type (2015-2020)
Figure 24. Global High Potency API Revenue Market Share by Type in 2019
Figure 25. Global High Potency API Market Share by Price Range (2015-2020)
Figure 26. Global High Potency API Sales Market Share by Application (2015-2020)
Figure 27. Global High Potency API Sales Market Share by Application in 2019
Figure 28. Global High Potency API Revenue Market Share by Application (2015-2020)
Figure 29. Global High Potency API Revenue Market Share by Application in 2019
Figure 30. North America High Potency API Sales Growth Rate 2015-2020 (K MT)
Figure 31. North America High Potency API Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America High Potency API Sales Market Share by Country in 2019
Figure 33. North America High Potency API Revenue Market Share by Country in 2019
Figure 34. U.S. High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.S. High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 37. Canada High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America High Potency API Market Share by Type in 2019
Figure 39. North America High Potency API Market Share by Application in 2019
Figure 40. Europe High Potency API Sales Growth Rate 2015-2020 (K MT)
Figure 41. Europe High Potency API Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe High Potency API Sales Market Share by Country in 2019
Figure 43. Europe High Potency API Revenue Market Share by Country in 2019
Figure 44. Germany High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 45. Germany High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 47. France High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 49. U.K. High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 51. Italy High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 53. Russia High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe High Potency API Market Share by Type in 2019
Figure 55. Europe High Potency API Market Share by Application in 2019
Figure 56. Asia Pacific High Potency API Sales Growth Rate 2015-2020 (K MT)
Figure 57. Asia Pacific High Potency API Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific High Potency API Sales Market Share by Region in 2019
Figure 59. Asia Pacific High Potency API Revenue Market Share by Region in 2019
Figure 60. China High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 61. China High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 63. Japan High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 65. South Korea High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 67. India High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 69. Australia High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 71. Taiwan High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 73. Indonesia High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 75. Thailand High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 77. Malaysia High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 79. Philippines High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 81. Vietnam High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific High Potency API Market Share by Type in 2019
Figure 83. Asia Pacific High Potency API Market Share by Application in 2019
Figure 84. Latin America High Potency API Sales Growth Rate 2015-2020 (K MT)
Figure 85. Latin America High Potency API Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America High Potency API Sales Market Share by Country in 2019
Figure 87. Latin America High Potency API Revenue Market Share by Country in 2019
Figure 88. Mexico High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 89. Mexico High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 91. Brazil High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 93. Argentina High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America High Potency API Market Share by Type in 2019
Figure 95. Latin America High Potency API Market Share by Application in 2019
Figure 96. Middle East and Africa High Potency API Sales Growth Rate 2015-2020 (K MT)
Figure 97. Middle East and Africa High Potency API Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa High Potency API Sales Market Share by Country in 2019
Figure 99. Middle East and Africa High Potency API Revenue Market Share by Country in 2019
Figure 100. Turkey High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 101. Turkey High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 103. Saudi Arabia High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 105. U.A.E High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa High Potency API Market Share by Type in 2019
Figure 107. Middle East and Africa High Potency API Market Share by Application in 2019
Figure 108. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Novartis International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Teva Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Merck & Co Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. North America High Potency API Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 122. North America High Potency API Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Europe High Potency API Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 124. Europe High Potency API Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Asia Pacific High Potency API Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 126. Asia Pacific High Potency API Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Latin America High Potency API Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 128. Latin America High Potency API Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Middle East and Africa High Potency API Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 130. Middle East and Africa High Potency API Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 131. Porter's Five Forces Analysis
Figure 132. Channels of Distribution
Figure 133. Distributors Profiles
Figure 134. Bottom-up and Top-down Approaches for This Report
Figure 135. Data Triangulation
Figure 136. Key Executives Interviewed
Figure 1. High Potency API Product Picture
Figure 2. Global High Potency API Sales Market Share by Type in 2020 & 2026
Figure 3. Synthetic HPAPIs Product Picture
Figure 4. Biotech HPAPIs Product Picture
Figure 5. Global High Potency API Sales Market Share by Application in 2020 & 2026
Figure 6. Oncology
Figure 7. Hormonal Disorders
Figure 8. Glaucoma
Figure 9. Other
Figure 10. High Potency API Report Years Considered
Figure 11. Global High Potency API Market Size 2015-2026 (US$ Million)
Figure 12. Global High Potency API Sales 2015-2026 (K MT)
Figure 13. Global High Potency API Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global High Potency API Sales Market Share by Region (2015-2020)
Figure 15. Global High Potency API Sales Market Share by Region in 2019
Figure 16. Global High Potency API Revenue Market Share by Region (2015-2020)
Figure 17. Global High Potency API Revenue Market Share by Region in 2019
Figure 18. Global High Potency API Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by High Potency API Revenue in 2019
Figure 20. High Potency API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global High Potency API Sales Market Share by Type (2015-2020)
Figure 22. Global High Potency API Sales Market Share by Type in 2019
Figure 23. Global High Potency API Revenue Market Share by Type (2015-2020)
Figure 24. Global High Potency API Revenue Market Share by Type in 2019
Figure 25. Global High Potency API Market Share by Price Range (2015-2020)
Figure 26. Global High Potency API Sales Market Share by Application (2015-2020)
Figure 27. Global High Potency API Sales Market Share by Application in 2019
Figure 28. Global High Potency API Revenue Market Share by Application (2015-2020)
Figure 29. Global High Potency API Revenue Market Share by Application in 2019
Figure 30. North America High Potency API Sales Growth Rate 2015-2020 (K MT)
Figure 31. North America High Potency API Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America High Potency API Sales Market Share by Country in 2019
Figure 33. North America High Potency API Revenue Market Share by Country in 2019
Figure 34. U.S. High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.S. High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 37. Canada High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America High Potency API Market Share by Type in 2019
Figure 39. North America High Potency API Market Share by Application in 2019
Figure 40. Europe High Potency API Sales Growth Rate 2015-2020 (K MT)
Figure 41. Europe High Potency API Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe High Potency API Sales Market Share by Country in 2019
Figure 43. Europe High Potency API Revenue Market Share by Country in 2019
Figure 44. Germany High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 45. Germany High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 47. France High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 49. U.K. High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 51. Italy High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 53. Russia High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe High Potency API Market Share by Type in 2019
Figure 55. Europe High Potency API Market Share by Application in 2019
Figure 56. Asia Pacific High Potency API Sales Growth Rate 2015-2020 (K MT)
Figure 57. Asia Pacific High Potency API Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific High Potency API Sales Market Share by Region in 2019
Figure 59. Asia Pacific High Potency API Revenue Market Share by Region in 2019
Figure 60. China High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 61. China High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 63. Japan High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 65. South Korea High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 67. India High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 69. Australia High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 71. Taiwan High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 73. Indonesia High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 75. Thailand High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 77. Malaysia High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 79. Philippines High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 81. Vietnam High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific High Potency API Market Share by Type in 2019
Figure 83. Asia Pacific High Potency API Market Share by Application in 2019
Figure 84. Latin America High Potency API Sales Growth Rate 2015-2020 (K MT)
Figure 85. Latin America High Potency API Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America High Potency API Sales Market Share by Country in 2019
Figure 87. Latin America High Potency API Revenue Market Share by Country in 2019
Figure 88. Mexico High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 89. Mexico High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 91. Brazil High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 93. Argentina High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America High Potency API Market Share by Type in 2019
Figure 95. Latin America High Potency API Market Share by Application in 2019
Figure 96. Middle East and Africa High Potency API Sales Growth Rate 2015-2020 (K MT)
Figure 97. Middle East and Africa High Potency API Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa High Potency API Sales Market Share by Country in 2019
Figure 99. Middle East and Africa High Potency API Revenue Market Share by Country in 2019
Figure 100. Turkey High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 101. Turkey High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 103. Saudi Arabia High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E High Potency API Sales Growth Rate (2015-2020) (K MT)
Figure 105. U.A.E High Potency API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa High Potency API Market Share by Type in 2019
Figure 107. Middle East and Africa High Potency API Market Share by Application in 2019
Figure 108. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Novartis International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Teva Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Merck & Co Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. North America High Potency API Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 122. North America High Potency API Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Europe High Potency API Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 124. Europe High Potency API Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Asia Pacific High Potency API Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 126. Asia Pacific High Potency API Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Latin America High Potency API Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 128. Latin America High Potency API Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Middle East and Africa High Potency API Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 130. Middle East and Africa High Potency API Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 131. Porter's Five Forces Analysis
Figure 132. Channels of Distribution
Figure 133. Distributors Profiles
Figure 134. Bottom-up and Top-down Approaches for This Report
Figure 135. Data Triangulation
Figure 136. Key Executives Interviewed
